Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity

被引:56
作者
El-Mikkawy, Dalia M. E. [1 ]
EL-Sadek, Maha A. [1 ]
EL-Badawy, Mohja A. [1 ]
Samaha, Dalia [2 ]
机构
[1] Ain Shams Univ, Ain Shams Univ Hosp, Fac Med, Dept Phys Med Rheumatol & Rehabil, 11 Abbass Zaaezooe,7th, Cairo 11727, Egypt
[2] Ain Shams Univ, Ain Shams Univ Hosp, Fac Med, Dept Clin Pathol, Cairo, Egypt
关键词
Interleukin; 6; Obesity; Pro-inflammatory cytokines; Body mass index; High-density lipoprotein; Cholesterol;
D O I
10.1186/s43166-020-00003-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Obesity is an important feature of metabolic syndrome, and the link between them has been attributed to the state of chronic inflammatory process. The purpose of the study is to investigate the relation of circulating level of IL-6 as an inflammatory cytokine to body mass index and lipid profile in adults with overweight and obesity. Methods This cross-sectional study included 15 adults with overweight, 45 with obesity (15 grade I, 15 grade II, and 15 grade III), and 25 average weight controls. Circulating IL-6 level and lipid profile were measured. Results Highly significant differences were found between study groups in different grades of obesity as regards weight, body mass index, serum triglycerides, and serum LDL-C. Circulating levels of IL6 were significantly higher in subjects with overweight and obesity. There were significantly positive correlations between circulating levels of IL6 and BMI in subjects with grade III obesity and negative correlation with serum HDL-C in subjects with grade II obesity. Conclusion High circulating level of IL-6 could reflect the intensity of the chronic and systemic inflammation that develops with high degrees of obesity, which might contribute to the development of atherosclerosis and coronary heart diseases, both directly and by reducing HDL-C levels.
引用
收藏
页数:7
相关论文
共 41 条
  • [21] Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI200316146, 10.1172/JCI16146]
  • [22] Tocilizumab - A novel therapy for non-organ-specific autoimmune diseases
    Kaly, Lisa
    Rosner, Itzhak
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (01): : 157 - 165
  • [23] IL-6 signal transduction and its physiological roles: the signal orchestration model
    Kamimura, D
    Ishihara, K
    Hirano, T
    [J]. REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 149, 2004, 149 : 1 - 38
  • [24] Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745
  • [25] Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity
    Khaodhiar, L
    Ling, PR
    Blackburn, GL
    Bistrian, BR
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2004, 28 (06) : 410 - 415
  • [26] Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
    Lowe, Gordon
    Woodward, Mark
    Hillis, Graham
    Rumley, Ann
    Li, Qiang
    Harrap, Stephen
    Marre, Michel
    Hamet, Pavel
    Patel, Anushka
    Poulter, Neil
    Chalmers, John
    [J]. DIABETES, 2014, 63 (03) : 1115 - 1123
  • [27] Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo
    Mohamed-Ali, V
    Goodrick, S
    Rawesh, A
    Katz, DR
    Miles, JM
    Yudkin, JS
    Klein, S
    Coppack, SW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 4196 - 4200
  • [28] High-density lipoprotein cholesterol: origins and the path ahead
    Oda, Michael N.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2015, 22 (02) : 133 - 141
  • [29] Editorial: Interleukin-6: The endocrine cytokine
    Papanicolaou, DA
    Vgontzas, AN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) : 1331 - 1333
  • [30] Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
    Popa, C
    Netea, MG
    Radstake, T
    Van der Meer, JWM
    Stalenhoef, AFH
    van Riel, PLCM
    Barerra, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 303 - 305